Literature DB >> 7679951

Monoclonal antibody uptake in B-cell lymphomas: experimental studies in nude mouse xenografts.

J Schmid1, P Möller, G Moldenhauer, B Dörken, H Bihl, S Matzku.   

Abstract

Accumulation of radiolabelled monoclonal antibodies (mAb) in human B-lymphoma xenografts was found to result in two distinct patterns. The basic elements leading to these patterns were elucidated by autoradiographic and immunohistological analysis applied to the nude mouse xenografts BJAB and OCI.LY1. With BJAB, accumulation occurred exclusively in peripheral cell layers of the lymphoma nodule, while central areas were not accessible irrespective of mAb dose. This feature was the consequence of an inefficient transport across intratumoral vessels together with peripheral mAb supply through a subcapsular pseudosinus. With OCI.LY1, intratumoral vessels showed generalized leakiness. Furthermore, interstitial transport was operative to a fair extent, such that in early images multiple sites of mAb extravasation were obvious, which coalesced during the course of prolonged uptake. The pattern of peripheral mAb uptake resulted in a low overall tumour uptake, while multifocal uptake yielded substantial accumulation values.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679951     DOI: 10.1007/bf01740910

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

Review 1.  Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.

Authors:  R K Jain
Journal:  J Natl Cancer Inst       Date:  1989-04-19       Impact factor: 13.506

2.  Quantitation of antibody uptake in spontaneous metastases.

Authors:  U Schmid; V Schirrmacher; H Bihl; S Matzku
Journal:  Br J Cancer Suppl       Date:  1990-07

3.  Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts.

Authors:  H Sands; P L Jones; S A Shah; D Palme; R L Vessella; B M Gallagher
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

4.  Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Authors:  B C Trauth; C Klas; A M Peters; S Matzku; P Möller; W Falk; K M Debatin; P H Krammer
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

5.  Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA.

Authors:  S Matzku; H Kirchgessner; U Schmid; M Temponi; S Ferrone
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

6.  Autoradiographic evaluation of monoclonal antibodies' access to melanoma-associated antigens in melanoma xenografts.

Authors:  S Matzku; J Schmid; W Tilgen
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

7.  A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

Authors:  K Fujimori; D G Covell; J E Fletcher; J N Weinstein
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

8.  The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.

Authors:  M E Tweeddale; B Lim; N Jamal; J Robinson; J Zalcberg; G Lockwood; M D Minden; H A Messner
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.

Authors:  K Fujimori; D G Covell; J E Fletcher; J N Weinstein
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

View more
  2 in total

1.  Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modeling.

Authors:  Peter Kletting; Christoph Meyer; Sven N Reske; Gerhard Glatting
Journal:  Cancer Biother Radiopharm       Date:  2010-06       Impact factor: 3.099

2.  Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments.

Authors:  R B Michel; M J Mattes
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.